Design Considerations in the PSMAfore Trial

J Nucl Med. 2024 Feb 1;65(2):226-227. doi: 10.2967/jnumed.123.267034.

Authors

Oliver Sartor¹, Karim Fizazi², Ken Herrmann³, Michael J Morris⁴

Affiliations

¹ Mayo Clinic, Rochester, Minnesota; osartor@tulane.edu.
² Institute Gustave Roussy, Paris, France.
³ University Hospital Essen, Essen, Germany; and.
⁴ Memorial Sloan Kettering Cancer Center, New York, New York.

PMID: 38302161
DOI: 10.2967/jnumed.123.267034

No abstract available

Publication types

Comment